Durvalumab + tremelimumab immune checkpoint inhibition

CP 675206 - CP675206 - CP-675206 - CP-675,206 - CP-675 - P675 cpd - CP 675 - ticilimumab      

pdf
pathology k Demonstrated benefit and harm